In the intricate world of medical advancements, the quality and source of stem cells play a pivotal role, especially when it comes to the potency of exosomes.
With numerous companies venturing into this realm, how can one discern the genuine from the dubious? Dr. Joshua Crose, in his enlightening video, delves deep into this very topic, shedding light on the significance of stem cell sources and their impact on exosome quality.
Dr. Crose begins by referencing a talk he recently gave on the significance of stem cell sources and their impact on exosome quality. He emphasizes the challenges consumers face in determining the quality of exosomes, noting that many doctors are unaware of the specifics.
Dr. Crose points out that a large number of companies are not transparent about their stem cell sources and the quality of their products. Some of these companies rely on a single quality measure from an initial batch produced years ago and claim it applies to all their subsequent batches. This means they aren’t consistently testing every batch.
He further elaborates on the importance of companies providing nanoparticle analysis, proteomics, and growth factor analysis for each lot. Without these, consumers cannot be certain of the product’s quality.
Dr. Crose advises consumers to request this information from companies. If companies are unable or unwilling to provide this data, he warns that they might be deceptive about their product’s quality.
In conclusion, Dr. Joshua Crose stresses the importance of being an educated medical provider and consumer when it comes to exosomes. It’s crucial to ask the right questions and be wary of companies that don’t offer transparency about their products.